Free Trial

Darling Ingredients (DAR) Financials

Darling Ingredients logo
$31.51 -0.84 (-2.60%)
Closing price 05/28/2025 03:59 PM Eastern
Extended Trading
$31.40 -0.12 (-0.36%)
As of 05/28/2025 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Darling Ingredients

Annual Income Statements for Darling Ingredients

This table shows Darling Ingredients' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/28/2024 12/30/2023 12/31/2022 1/1/2022 1/2/2021 12/28/2019 12/29/2018 12/30/2017 12/31/2016 1/2/2016
Net Income / (Loss) Attributable to Common Shareholders
279 648 738 651 297 313 101 128 102 79
Consolidated Net Income / (Loss)
286 660 747 657 300 321 106 133 107 85
Net Income / (Loss) Continuing Operations
286 660 747 657 300 321 106 133 107 85
Total Pre-Tax Income
248 720 894 821 354 380 118 64 123 99
Total Operating Income
468 950 1,029 884 431 476 255 169 155 143
Total Gross Profit
1,278 1,645 1,530 1,242 883 775 741 787 757 737
Total Revenue
5,715 6,788 6,532 4,741 3,572 3,364 3,388 3,662 3,392 3,391
Operating Revenue
5,715 6,788 6,532 4,741 3,572 3,364 3,388 3,662 3,392 3,391
Total Cost of Revenue
4,437 5,143 5,003 3,499 2,689 2,589 2,646 2,876 2,635 2,654
Operating Cost of Revenue
4,437 5,143 5,003 3,499 2,689 2,589 2,646 2,876 2,635 2,654
Total Operating Expenses
810 695 501 358 452 299 486 617 602 595
Selling, General & Admin Expense
492 543 437 392 378 359 309 344 312 316
Depreciation Expense
504 502 395 316 350 326 321 302 290 270
Other Operating Expenses / (Income)
-149 -366 -372 -352 -315 -364 -160 -28 - -
Restructuring Charge
14 32 46 2.17 38 0.00 15 0.00 0.40 8.30
Other Special Charges / (Income)
-51 -15 -4.49 -0.96 0.43 -21 0.71 -0.24 - -
Total Other Income / (Expense), net
-221 -230 -135 -63 -77 -95 -137 -105 -32 -44
Interest Expense
254 259 126 62 73 91 110 89 94 106
Interest & Investment Income
12 5.01 5.10 5.75 3.19 0.43 -0.55 0.27 70 73
Other Income / (Expense), net
21 24 -15 -6.75 -7.82 -5.02 -27 -17 -8.39 -12
Income Tax Expense
-38 60 147 164 53 59 12 -69 15 14
Net Income / (Loss) Attributable to Noncontrolling Interest
6.97 13 9.40 6.38 3.51 8.37 4.45 4.89 4.91 6.75
Basic Earnings per Share
$1.75 $4.05 $4.58 $4.01 $1.83 $1.90 $0.62 $0.78 $0.62 $0.48
Weighted Average Basic Shares Outstanding
158.87M 159.61M 159.95M 161.10M 162.60M 163.92M 164.79M 164.75M 164.60M 165.03M
Diluted Earnings per Share
$1.73 $3.99 $4.49 $3.90 $1.78 $1.86 $0.60 $0.77 $0.62 $0.48
Weighted Average Diluted Shares Outstanding
158.87M 159.61M 159.95M 161.10M 162.60M 163.92M 164.79M 164.75M 164.60M 165.03M
Weighted Average Basic & Diluted Shares Outstanding
158.87M 159.61M 159.95M 161.10M 162.60M 163.92M 164.79M 164.75M 164.60M 165.03M

Quarterly Income Statements for Darling Ingredients

This table shows Darling Ingredients' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/29/2025 12/28/2024 9/28/2024 6/29/2024 3/30/2024 12/30/2023 9/30/2023 7/1/2023 4/1/2023 12/31/2022 10/1/2022
Net Income / (Loss) Attributable to Common Shareholders
-26 102 17 79 81 85 125 252 186 157 191
Consolidated Net Income / (Loss)
-24 104 19 81 82 87 128 255 190 159 192
Net Income / (Loss) Continuing Operations
-24 104 19 81 82 87 128 255 190 159 192
Total Pre-Tax Income
-25 78 1.64 82 85 95 113 296 217 197 228
Total Operating Income
28 122 60 149 137 159 178 357 256 249 268
Total Gross Profit
311 334 314 327 304 436 386 398 424 389 376
Total Revenue
1,381 1,418 1,422 1,455 1,420 1,614 1,625 1,758 1,791 1,768 1,748
Operating Revenue
1,381 1,418 1,422 1,455 1,420 1,614 1,625 1,758 1,791 1,768 1,748
Total Cost of Revenue
1,069 1,084 1,108 1,128 1,117 1,178 1,239 1,360 1,367 1,379 1,371
Operating Cost of Revenue
1,069 1,084 1,108 1,128 1,117 1,178 1,239 1,360 1,367 1,379 1,371
Total Operating Expenses
283 211 253 178 166 278 208 41 168 140 108
Selling, General & Admin Expense
122 108 116 130 139 133 138 137 135 122 105
Depreciation Expense
124 128 124 125 128 138 126 122 116 117 105
Other Operating Expenses / (Income)
31 -24 -2.43 -44 -78 -4.69 -54 -213 -94 -123 -103
Restructuring Charge
1.53 8.23 0.22 1.13 4.05 15 3.43 2.60 12 24 4.50
Other Special Charges / (Income)
5.50 -8.55 16 -33 -26 -3.12 -4.63 -7.24 -0.33 0.07 -3.12
Total Other Income / (Expense), net
-53 -44 -58 -66 -52 -64 -66 -61 -39 -52 -41
Interest Expense
58 55 67 69 63 68 70 70 50 46 40
Interest & Investment Income
2.63 2.89 3.78 3.02 2.31 1.51 1.53 1.85 0.12 -0.83 2.30
Other Income / (Expense), net
1.97 7.82 4.60 -0.16 8.89 2.62 3.09 7.57 11 -5.03 -3.30
Income Tax Expense
-1.15 -26 -17 0.77 3.91 7.25 -15 41 27 38 35
Net Income / (Loss) Attributable to Noncontrolling Interest
2.35 1.87 2.17 2.50 0.43 2.74 3.06 2.81 4.05 2.67 1.22
Basic Earnings per Share
($0.16) $0.64 $0.11 $0.49 $0.51 $0.53 $0.78 $1.58 $1.16 $0.97 $1.19
Weighted Average Basic Shares Outstanding
158.16M 158.87M 159.05M 159.02M 159.78M 159.61M 159.53M 159.49M 159.56M 159.95M 160.27M
Diluted Earnings per Share
($0.16) $0.63 $0.11 $0.49 $0.50 $0.53 $0.77 $1.55 $1.14 $0.95 $1.17
Weighted Average Diluted Shares Outstanding
158.16M 158.87M 159.05M 159.02M 159.78M 159.61M 159.53M 159.49M 159.56M 159.95M 160.27M
Weighted Average Basic & Diluted Shares Outstanding
158.16M 158.87M 159.05M 159.02M 159.78M 159.61M 159.53M 159.49M 159.56M 159.95M 160.27M

Annual Cash Flow Statements for Darling Ingredients

This table details how cash moves in and out of Darling Ingredients' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/28/2024 12/30/2023 12/31/2022 1/1/2022 1/2/2021 12/28/2019 12/29/2018 12/30/2017 12/31/2016 1/2/2016
Net Change in Cash & Equivalents
-47 114 81 -13 8.68 -34 0.45 -7.94 -42 48
Net Cash From Operating Activities
839 899 814 704 625 363 399 410 391 421
Net Cash From Continuing Operating Activities
839 899 814 704 625 363 399 410 391 421
Net Income / (Loss) Continuing Operations
286 660 747 657 300 321 106 133 107 85
Consolidated Net Income / (Loss)
286 660 747 657 300 321 106 133 107 85
Depreciation Expense
504 502 395 316 350 326 321 302 290 270
Amortization Expense
5.62 6.22 4.98 4.04 5.36 5.85 7.87 8.74 11 10
Non-Cash Adjustments To Reconcile Net Income
185 -136 -362 -404 -65 -325 -32 0.82 -16 8.09
Changes in Operating Assets and Liabilities, net
-141 -133 29 130 34 35 -4.71 -35 -0.83 48
Net Cash From Investing Activities
-499 -1,675 -2,417 -490 -311 -338 -342 -284 -243 -230
Net Cash From Continuing Investing Activities
-499 -1,675 -2,417 -490 -311 -338 -342 -284 -243 -230
Purchase of Property, Plant & Equipment
-332 -555 -391 -274 -280 -359 -322 -274 -244 -230
Acquisitions
-207 -1,170 -2,039 -191 -34 -5.08 -112 -19 -8.53 -4.22
Other Investing Activities, net
40 50 13 -25 3.09 23 21 14 8.87 4.40
Net Cash From Financing Activities
-400 876 1,679 -221 -307 -55 -48 -155 -184 -140
Net Cash From Continuing Financing Activities
-400 876 1,679 -221 -307 -55 -48 -155 -184 -140
Repayment of Debt
-1,790 -2,524 -1,953 -665 -755 -1,011 -696 -362 -312 -795
Repurchase of Common Equity
-34 -53 -126 -168 -55 -19 0.00 0.00 -5.00 -5.91
Payment of Dividends
-11 -9.08 -4.53 -6.02 -6.25 -6.53 -10 -23 -1.55 -3.38
Issuance of Debt
1,443 3,483 3,809 664 530 987 1,172 233 137 669
Issuance of Common Equity
0.45 0.00 0.00 0.05 0.07 0.04 0.18 0.02 0.19 0.17
Other Financing Activities, net
-8.14 -21 -47 -47 -21 -4.47 -513 -3.05 -1.84 -4.87
Effect of Exchange Rate Changes
12 14 5.30 -5.45 1.64 -3.99 -8.17 21 -6.30 -3.60

Quarterly Cash Flow Statements for Darling Ingredients

This table details how cash moves in and out of Darling Ingredients' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/29/2025 12/28/2024 9/28/2024 6/29/2024 3/30/2024 12/30/2023 9/30/2023 7/1/2023 4/1/2023 12/31/2022 10/1/2022
Net Change in Cash & Equivalents
6.86 -44 -4.65 -27 28 11 9.41 -18 112 2.81 0.52
Net Cash From Operating Activities
249 154 274 147 264 217 277 217 188 175 277
Net Cash From Continuing Operating Activities
249 154 274 147 264 217 277 217 188 175 277
Net Income / (Loss) Continuing Operations
-24 104 19 81 82 87 128 255 190 159 192
Consolidated Net Income / (Loss)
-24 104 19 81 82 87 128 255 190 159 192
Depreciation Expense
124 128 124 125 128 138 126 122 116 117 105
Amortization Expense
1.43 1.42 1.42 1.40 1.40 1.54 1.54 1.52 1.62 1.43 1.35
Non-Cash Adjustments To Reconcile Net Income
144 34 139 11 1.42 69 18 -106 -117 -85 -55
Changes in Operating Assets and Liabilities, net
3.69 -113 -8.33 -72 52 -79 2.92 -55 -1.56 -18 34
Net Cash From Investing Activities
-51 -46 -65 -97 -291 -169 -158 -92 -1,257 -194 -598
Net Cash From Continuing Investing Activities
-51 -46 -65 -97 -291 -169 -158 -92 -1,257 -194 -598
Purchase of Property, Plant & Equipment
-63 -73 -67 -98 -94 -175 -146 -123 -111 -134 -106
Acquisitions
-0.15 -0.00 0.20 -6.98 -200 -0.00 -14 - -1,156 -39 -525
Other Investing Activities, net
12 27 2.27 8.24 2.76 6.11 2.08 31 10 -21 32
Net Cash From Financing Activities
-185 -166 -201 -81 49 -26 -118 -153 1,173 -4.30 325
Net Cash From Continuing Financing Activities
-185 -166 -201 -81 49 -26 -118 -153 1,173 -4.30 325
Repayment of Debt
-237 -264 -406 -587 -533 -720 -674 -867 -263 -174 -806
Repurchase of Common Equity
-35 -5.08 - -29 0.00 - - -9.15 -44 -22 -37
Issuance of Debt
93 105 212 538 588 698 561 729 1,495 194 1,173
Issuance of Common Equity
0.34 0.01 - - 0.44 - - - 0.00 - -
Other Financing Activities, net
-6.54 -0.16 -0.78 -0.30 -6.91 -3.81 -1.72 -0.26 -15 -0.55 -0.56
Effect of Exchange Rate Changes
-6.21 15 -13 4.11 6.47 -11 9.02 9.25 7.28 26 -4.24

Annual Balance Sheets for Darling Ingredients

This table presents Darling Ingredients' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/28/2024 12/30/2023 12/31/2022 1/1/2022 1/2/2021 12/28/2019 12/29/2018 12/30/2017 12/31/2016 1/2/2016
Total Assets
10,070 11,061 9,202 6,134 5,613 5,345 4,889 4,958 4,698 4,761
Total Current Assets
1,439 1,856 1,638 1,089 987 917 898 956 893 932
Cash & Equivalents
76 127 127 69 82 73 107 107 115 157
Restricted Cash
38 0.29 0.32 0.17 0.10 0.11 0.11 0.14 0.29 0.33
Accounts Receivable
591 798 677 469 405 406 386 392 388 371
Inventories, net
577 759 674 457 406 363 341 358 331 345
Prepaid Expenses
81 106 86 54 48 47 35 38 30 36
Current Deferred & Refundable Income Taxes
35 24 19 1.08 3.88 3.32 6.46 4.51 7.48 12
Other Current Assets
42 43 56 39 42 25 22 57 22 10
Plant, Property, & Equipment, net
2,714 2,935 2,462 1,840 1,864 1,802 1,688 1,646 1,516 1,508
Total Noncurrent Assets
5,917 6,270 5,102 3,205 2,763 2,626 2,304 2,356 2,289 2,321
Long-Term Investments
2,264 2,252 1,926 1,349 805 689 410 302 293 247
Goodwill
2,323 2,485 1,970 1,219 1,260 1,223 1,229 1,301 1,226 1,233
Intangible Assets
898 1,076 865 398 474 526 596 677 712 782
Noncurrent Deferred & Refundable Income Taxes
22 18 18 16 17 14 15 14 15 16
Other Noncurrent Operating Assets
410 440 322 222 207 172 53 62 44 42
Total Liabilities & Shareholders' Equity
10,070 11,061 9,202 6,134 5,613 5,345 4,889 4,958 4,698 4,761
Total Liabilities
5,606 6,367 5,306 2,786 2,659 2,702 2,554 2,631 2,622 2,786
Total Current Liabilities
1,044 998 1,068 753 675 688 540 559 452 442
Short-Term Debt
133 61 70 24 28 91 7.49 16 23 45
Accounts Payable
349 426 472 307 255 239 219 217 181 150
Accrued Expenses
489 441 432 351 335 311 309 314 243 240
Current Deferred & Payable Income Tax Liabilities
9.72 16 45 32 17 8.90 4.04 12 4.91 6.68
Other Current Liabilities
63 55 49 38 39 38 0.00 - - -
Total Noncurrent Liabilities
4,563 5,369 4,237 2,033 1,984 2,014 2,013 2,071 2,170 2,344
Long-Term Debt
3,909 4,366 3,315 1,439 1,481 1,558 1,667 1,698 1,728 1,886
Noncurrent Deferred & Payable Income Tax Liabilities
293 498 482 363 276 248 231 267 346 361
Other Noncurrent Operating Liabilities
361 505 441 231 227 207 115 106 96 98
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,464 4,694 3,896 3,348 2,954 2,643 2,336 2,328 2,076 1,975
Total Preferred & Common Equity
4,378 4,605 3,809 3,281 2,892 2,566 2,273 2,245 1,973 1,871
Total Common Equity
4,378 4,605 3,809 3,281 2,892 2,566 2,273 2,245 1,973 1,871
Common Stock
1,723 1,700 1,662 1,630 1,599 1,563 1,538 1,517 1,501 1,490
Retained Earnings
4,012 3,733 3,086 2,348 1,697 1,400 1,088 981 853 750
Treasury Stock
-673 -629 -554 -375 -152 -75 -48 -44 -41 -34
Accumulated Other Comprehensive Income / (Loss)
-684 -198 -384 -322 -252 -322 -305 -210 -340 -336
Noncontrolling Interest
86 88 87 67 62 78 63 83 103 104

Quarterly Balance Sheets for Darling Ingredients

This table presents Darling Ingredients' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/29/2025 9/28/2024 6/29/2024 3/30/2024 9/30/2023 7/1/2023 4/1/2023 10/1/2022
Total Assets
10,032 10,573 10,621 10,943 10,810 10,973 10,861 8,809
Total Current Assets
1,455 1,497 1,508 1,619 1,843 1,876 1,903 1,562
Cash & Equivalents
81 115 122 145 119 112 133 126
Restricted Cash
40 39 26 4.09 0.30 0.30 0.30 0.10
Accounts Receivable
597 577 577 624 736 747 751 670
Inventories, net
595 618 628 687 823 825 829 642
Prepaid Expenses
90 85 89 98 102 117 109 80
Current Deferred & Refundable Income Taxes
25 40 34 32 26 23 20 18
Other Current Assets
26 24 32 28 38 53 61 26
Plant, Property, & Equipment, net
2,739 2,856 2,841 2,910 2,799 2,775 2,713 2,346
Total Noncurrent Assets
5,838 6,220 6,272 6,413 6,169 6,323 6,246 4,901
Long-Term Investments
2,112 2,332 2,416 2,379 2,164 2,214 2,125 1,815
Goodwill
2,389 2,456 2,418 2,498 2,447 2,566 2,588 1,900
Intangible Assets
898 977 993 1,057 1,091 1,075 1,091 874
Noncurrent Deferred & Refundable Income Taxes
18 19 17 17 25 25 21 15
Other Noncurrent Operating Assets
421 436 429 462 441 443 421 298
Total Liabilities & Shareholders' Equity
10,032 10,573 10,621 10,943 10,810 10,973 10,861 8,809
Total Liabilities
5,496 5,938 6,078 6,260 6,343 6,523 6,740 5,140
Total Current Liabilities
1,036 1,063 963 967 1,034 1,014 1,099 1,028
Short-Term Debt
117 114 92 103 74 88 119 64
Accounts Payable
348 332 350 343 395 427 434 398
Accrued Expenses
492 542 450 450 494 420 463 479
Current Deferred & Payable Income Tax Liabilities
15 15 13 12 18 30 38 43
Other Current Liabilities
64 60 58 59 52 48 45 44
Total Noncurrent Liabilities
4,461 4,876 5,115 5,292 5,310 5,509 5,641 4,112
Long-Term Debt
3,805 4,132 4,317 4,363 4,338 4,459 4,559 3,221
Noncurrent Deferred & Payable Income Tax Liabilities
289 375 401 464 503 562 523 462
Other Noncurrent Operating Liabilities
366 369 397 465 469 488 559 429
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
4,536 4,634 4,543 4,683 4,467 4,451 4,122 3,669
Total Preferred & Common Equity
4,448 4,551 4,461 4,593 4,381 4,368 4,033 3,580
Total Common Equity
4,448 4,551 4,461 4,593 4,381 4,368 4,033 3,580
Common Stock
1,725 1,726 1,725 1,714 1,693 1,682 1,675 1,654
Retained Earnings
3,986 3,910 3,893 3,814 3,649 3,524 3,271 2,929
Treasury Stock
-719 -667 -667 -637 -629 -625 -615 -530
Accumulated Other Comprehensive Income / (Loss)
-544 -418 -491 -298 -332 -213 -299 -473
Noncontrolling Interest
87 83 82 90 86 82 89 89

Annual Metrics And Ratios for Darling Ingredients

This table displays calculated financial ratios and metrics derived from Darling Ingredients' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/28/2024 12/30/2023 12/31/2022 1/1/2022 1/2/2021 12/28/2019 12/29/2018 12/30/2017 12/31/2016 1/2/2016
Growth Metrics
- - - - - - - - - -
Revenue Growth
-15.81% 3.92% 37.77% 32.74% 6.18% -0.70% -7.50% 7.97% 0.02% -14.29%
EBITDA Growth
-32.62% 4.85% 18.01% 53.88% -2.93% 43.88% 20.23% 3.64% 8.88% -4.59%
EBIT Growth
-49.77% -3.95% 15.55% 107.44% -10.13% 106.08% 49.46% 4.45% 11.81% -13.46%
NOPAT Growth
-37.93% 1.27% 21.54% 93.38% -8.83% 75.31% -34.94% 159.95% 9.95% -10.74%
Net Income Growth
-56.72% -11.61% 13.66% 118.86% -6.43% 202.96% -20.55% 24.37% 25.73% 24.84%
EPS Growth
-56.64% -11.14% 15.13% 119.10% -4.30% 210.00% -22.08% 24.19% 29.17% 23.08%
Operating Cash Flow Growth
-6.67% 10.51% 15.52% 12.77% 72.26% -9.03% -2.88% 4.97% -7.12% 52.98%
Free Cash Flow Firm Growth
279.31% 33.95% -209.40% 177.94% -11.90% -1.48% 166.36% -36.11% -57.76% 128.04%
Invested Capital Growth
-9.10% 28.98% 54.08% -5.12% 1.29% 1.08% -3.86% 6.24% -2.33% -10.04%
Revenue Q/Q Growth
-3.32% -2.22% 7.54% 6.52% 4.70% 0.19% -2.85% 1.99% 2.34% -5.48%
EBITDA Q/Q Growth
-3.95% -4.02% 5.40% 11.18% -21.55% 16.55% 29.35% 5.87% 4.72% -2.97%
EBIT Q/Q Growth
-5.99% -7.83% 3.62% 18.38% -34.57% 31.55% 115.73% 17.73% 9.43% -9.47%
NOPAT Q/Q Growth
4.96% -5.92% 3.87% 18.32% -34.78% 38.00% -9.76% 225.64% -4.61% 5.78%
Net Income Q/Q Growth
6.13% -9.83% 0.22% 20.42% -39.65% 168.22% -37.95% 95.85% -29.19% 25.06%
EPS Q/Q Growth
6.14% -9.52% 0.00% 21.12% -39.66% 181.82% -39.39% 97.44% -30.34% 26.32%
Operating Cash Flow Q/Q Growth
-6.94% 4.86% -8.65% 16.19% 9.52% -21.44% 16.77% 8.24% -3.43% 7.24%
Free Cash Flow Firm Q/Q Growth
61.10% 2.02% -37.34% 42.80% -40.37% 10.82% 24.64% 93.01% -12.68% 1.54%
Invested Capital Q/Q Growth
-4.15% 2.23% 4.29% -2.36% 2.15% 1.54% -0.61% 2.15% -2.86% -3.47%
Profitability Metrics
- - - - - - - - - -
Gross Margin
22.36% 24.23% 23.42% 26.19% 24.72% 23.03% 21.88% 21.48% 22.31% 21.74%
EBITDA Margin
17.48% 21.84% 21.64% 25.27% 21.80% 23.85% 16.46% 12.66% 13.19% 12.12%
Operating Margin
8.19% 13.99% 15.75% 18.65% 12.06% 14.14% 7.53% 4.63% 4.56% 4.21%
EBIT Margin
8.56% 14.35% 15.53% 18.51% 11.85% 14.00% 6.74% 4.17% 4.31% 3.86%
Profit (Net Income) Margin
5.00% 9.73% 11.44% 13.86% 8.41% 9.54% 3.13% 3.64% 3.16% 2.51%
Tax Burden Percent
115.49% 91.73% 83.59% 80.02% 84.93% 84.37% 89.80% 207.72% 87.50% 86.33%
Interest Burden Percent
50.58% 73.90% 88.12% 93.58% 83.58% 80.80% 51.64% 42.00% 83.73% 75.47%
Effective Tax Rate
-15.49% 8.27% 16.41% 19.98% 15.07% 15.63% 10.20% -107.72% 12.50% 13.67%
Return on Invested Capital (ROIC)
8.40% 14.56% 19.96% 20.31% 10.30% 11.43% 6.43% 9.98% 3.91% 3.33%
ROIC Less NNEP Spread (ROIC-NNEP)
-5.33% 2.08% 3.51% 5.17% 1.60% 3.56% -3.57% -6.53% 1.95% 1.08%
Return on Net Nonoperating Assets (RNNOA)
-2.16% 0.82% 0.67% 0.55% 0.43% 1.46% -1.88% -3.93% 1.38% 0.91%
Return on Equity (ROE)
6.24% 15.38% 20.63% 20.86% 10.73% 12.89% 4.54% 6.06% 5.29% 4.24%
Cash Return on Invested Capital (CROIC)
17.93% -10.75% -22.61% 25.57% 9.02% 10.36% 10.36% 3.93% 6.27% 13.90%
Operating Return on Assets (OROA)
4.63% 9.62% 13.23% 14.94% 7.72% 9.20% 4.64% 3.17% 3.09% 2.65%
Return on Assets (ROA)
2.71% 6.52% 9.74% 11.19% 5.48% 6.27% 2.15% 2.76% 2.27% 1.73%
Return on Common Equity (ROCE)
6.12% 15.06% 20.19% 20.43% 10.46% 12.53% 4.40% 5.80% 5.02% 4.02%
Return on Equity Simple (ROE_SIMPLE)
6.53% 14.34% 19.61% 20.03% 10.39% 12.51% 4.66% 5.94% 5.43% 4.56%
Net Operating Profit after Tax (NOPAT)
541 871 860 708 366 401 229 352 135 123
NOPAT Margin
9.46% 12.83% 13.17% 14.93% 10.25% 11.93% 6.76% 9.61% 3.99% 3.63%
Net Nonoperating Expense Percent (NNEP)
13.73% 12.47% 16.44% 15.14% 8.71% 7.87% 10.00% 16.51% 1.96% 2.25%
Return On Investment Capital (ROIC_SIMPLE)
6.36% 9.55% 11.81% - - - - - - -
Cost of Revenue to Revenue
77.64% 75.77% 76.58% 73.81% 75.28% 76.97% 78.12% 78.52% 77.69% 78.26%
SG&A Expenses to Revenue
8.61% 7.99% 6.68% 8.26% 10.60% 10.66% 9.13% 9.38% 9.19% 9.33%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
14.17% 10.24% 7.66% 7.54% 12.66% 8.89% 14.36% 16.85% 17.74% 17.53%
Earnings before Interest and Taxes (EBIT)
489 974 1,014 878 423 471 228 153 146 131
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
999 1,482 1,414 1,198 779 802 558 464 447 411
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.22 1.73 2.63 3.42 3.23 1.79 1.38 1.33 1.08 0.93
Price to Tangible Book Value (P/TBV)
4.60 7.61 10.30 6.74 8.07 5.62 7.00 11.17 60.42 0.00
Price to Revenue (P/Rev)
0.93 1.17 1.54 2.36 2.62 1.36 0.93 0.82 0.63 0.51
Price to Earnings (P/E)
19.08 12.28 13.60 17.22 31.49 14.66 30.89 23.24 20.77 22.07
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.24% 8.15% 7.35% 5.81% 3.18% 6.82% 3.24% 4.30% 4.81% 4.53%
Enterprise Value to Invested Capital (EV/IC)
1.15 1.50 2.19 3.34 2.81 1.57 1.25 1.20 1.04 0.96
Enterprise Value to Revenue (EV/Rev)
1.24 1.49 1.75 2.39 2.81 1.65 1.29 1.19 1.05 0.99
Enterprise Value to EBITDA (EV/EBITDA)
7.08 6.81 8.10 9.45 12.88 6.92 7.81 9.43 7.98 8.18
Enterprise Value to EBIT (EV/EBIT)
14.45 10.36 11.29 12.90 23.71 11.79 19.06 28.61 24.41 25.70
Enterprise Value to NOPAT (EV/NOPAT)
13.08 11.58 13.31 16.00 27.41 13.82 19.02 12.43 26.38 27.31
Enterprise Value to Operating Cash Flow (EV/OCF)
8.43 11.22 14.07 16.08 16.06 15.30 10.92 10.66 9.13 7.99
Enterprise Value to Free Cash Flow (EV/FCFF)
6.13 0.00 0.00 12.71 31.30 15.25 11.79 31.55 16.46 6.55
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.91 0.94 0.87 0.44 0.51 0.62 0.72 0.74 0.84 0.98
Long-Term Debt to Equity
0.88 0.93 0.85 0.43 0.50 0.59 0.71 0.73 0.83 0.96
Financial Leverage
0.41 0.39 0.19 0.11 0.27 0.41 0.53 0.60 0.71 0.84
Leverage Ratio
2.31 2.36 2.12 1.86 1.96 2.06 2.11 2.19 2.34 2.46
Compound Leverage Factor
1.17 1.74 1.87 1.74 1.64 1.66 1.09 0.92 1.96 1.85
Debt to Total Capital
47.52% 48.54% 46.49% 30.42% 33.80% 38.42% 41.75% 42.41% 45.75% 49.44%
Short-Term Debt to Total Capital
1.56% 0.67% 0.96% 0.51% 0.62% 2.12% 0.19% 0.40% 0.61% 1.16%
Long-Term Debt to Total Capital
45.95% 47.87% 45.53% 29.91% 33.18% 36.30% 41.57% 42.01% 45.14% 48.29%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.02% 0.97% 1.20% 1.39% 1.40% 1.81% 1.57% 2.05% 2.70% 2.66%
Common Equity to Total Capital
51.47% 50.49% 52.31% 68.19% 64.81% 59.77% 56.68% 55.54% 51.55% 47.90%
Debt to EBITDA
4.05 2.99 2.39 1.22 1.94 2.06 3.00 3.70 3.91 4.70
Net Debt to EBITDA
1.67 1.38 0.94 0.04 0.80 1.11 2.08 2.81 3.00 3.71
Long-Term Debt to EBITDA
3.91 2.95 2.34 1.20 1.90 1.94 2.99 3.66 3.86 4.59
Debt to NOPAT
7.47 5.08 3.93 2.07 4.12 4.11 7.31 4.87 12.93 15.68
Net Debt to NOPAT
3.08 2.35 1.55 0.06 1.70 2.21 5.05 3.71 9.92 12.40
Long-Term Debt to NOPAT
7.23 5.01 3.85 2.03 4.05 3.88 7.28 4.82 12.76 15.31
Altman Z-Score
1.90 2.22 2.75 4.26 3.48 2.36 1.98 1.89 1.68 1.52
Noncontrolling Interest Sharing Ratio
1.91% 2.05% 2.13% 2.05% 2.50% 2.82% 3.12% 4.22% 5.11% 5.02%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.38 1.86 1.53 1.45 1.46 1.33 1.66 1.71 1.98 2.11
Quick Ratio
0.64 0.93 0.75 0.71 0.72 0.70 0.91 0.89 1.11 1.20
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,154 -644 -974 891 320 364 369 139 217 514
Operating Cash Flow to CapEx
252.44% 161.89% 207.95% 256.97% 223.00% 100.87% 123.83% 149.70% 160.56% 183.15%
Free Cash Flow to Firm to Interest Expense
4.55 -2.48 -7.76 14.35 4.41 4.01 3.36 1.56 2.30 4.87
Operating Cash Flow to Interest Expense
3.31 3.47 6.48 11.35 8.59 3.99 3.63 4.62 4.15 3.99
Operating Cash Flow Less CapEx to Interest Expense
2.00 1.33 3.36 6.93 4.74 0.03 0.70 1.53 1.57 1.81
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.54 0.67 0.85 0.81 0.65 0.66 0.69 0.76 0.72 0.69
Accounts Receivable Turnover
8.23 9.21 11.40 10.84 8.80 8.49 8.71 9.39 8.93 8.68
Inventory Turnover
6.64 7.18 8.85 8.11 6.99 7.36 7.57 8.35 7.80 7.11
Fixed Asset Turnover
2.02 2.52 3.04 2.56 1.95 1.93 2.03 2.32 2.24 2.20
Accounts Payable Turnover
11.46 11.45 12.83 12.44 10.87 11.29 12.11 14.44 15.93 16.66
Days Sales Outstanding (DSO)
44.35 39.65 32.01 33.66 41.47 42.97 41.89 38.88 40.88 42.04
Days Inventory Outstanding (DIO)
54.93 50.83 41.26 45.03 52.19 49.62 48.22 43.73 46.77 51.31
Days Payable Outstanding (DPO)
31.85 31.87 28.44 29.33 33.57 32.34 30.13 25.28 22.91 21.90
Cash Conversion Cycle (CCC)
67.43 58.61 44.83 49.35 60.09 60.26 59.98 57.33 64.74 71.45
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
6,129 6,742 5,228 3,393 3,576 3,530 3,493 3,633 3,420 3,501
Invested Capital Turnover
0.89 1.13 1.52 1.36 1.01 0.96 0.95 1.04 0.98 0.92
Increase / (Decrease) in Invested Capital
-613 1,515 1,835 -183 46 38 -140 213 -82 -391
Enterprise Value (EV)
7,073 10,088 11,450 11,324 10,032 5,548 4,355 4,374 3,572 3,363
Market Capitalization
5,322 7,951 10,031 11,212 9,348 4,584 3,135 2,986 2,125 1,733
Book Value per Share
$27.53 $28.87 $23.77 $20.28 $17.84 $15.67 $13.80 $13.63 $11.99 $11.36
Tangible Book Value per Share
$7.27 $6.55 $6.07 $10.28 $7.15 $4.99 $2.72 $1.62 $0.21 ($0.88)
Total Capital
8,506 9,121 7,281 4,811 4,462 4,293 4,010 4,042 3,827 3,906
Total Debt
4,042 4,427 3,385 1,463 1,508 1,649 1,674 1,714 1,751 1,931
Total Long-Term Debt
3,909 4,366 3,315 1,439 1,481 1,558 1,667 1,698 1,728 1,886
Net Debt
1,665 2,049 1,331 45 622 887 1,157 1,305 1,343 1,527
Capital Expenditures (CapEx)
332 555 391 274 280 359 322 274 244 230
Debt-free, Cash-free Net Working Capital (DFCFNWC)
415 791 512 292 258 247 258 306 350 378
Debt-free Net Working Capital (DFNWC)
529 918 640 361 339 320 365 413 465 535
Net Working Capital (NWC)
396 858 570 336 312 229 357 397 441 490
Net Nonoperating Expense (NNE)
255 211 113 50 66 80 123 219 28 38
Net Nonoperating Obligations (NNO)
1,665 2,049 1,331 45 622 887 1,157 1,305 1,343 1,527
Total Depreciation and Amortization (D&A)
509 508 400 320 356 331 329 311 301 280
Debt-free, Cash-free Net Working Capital to Revenue
7.27% 11.66% 7.84% 6.15% 7.21% 7.34% 7.60% 8.36% 10.31% 11.15%
Debt-free Net Working Capital to Revenue
9.26% 13.53% 9.79% 7.61% 9.50% 9.51% 10.77% 11.28% 13.70% 15.78%
Net Working Capital to Revenue
6.93% 12.63% 8.72% 7.09% 8.73% 6.81% 10.55% 10.84% 13.01% 14.45%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$1.75 $4.05 $4.58 $4.01 $1.83 $1.90 $0.62 $0.78 $0.62 $0.48
Adjusted Weighted Average Basic Shares Outstanding
158.87M 159.61M 159.95M 161.10M 162.60M 163.92M 164.66M 164.68M 164.71M 164.17M
Adjusted Diluted Earnings per Share
$1.73 $3.99 $4.49 $3.90 $1.78 $1.86 $0.60 $0.77 $0.62 $0.48
Adjusted Weighted Average Diluted Shares Outstanding
158.87M 159.61M 159.95M 161.10M 162.60M 163.92M 164.66M 164.68M 164.71M 164.17M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
158.87M 159.61M 159.95M 161.10M 162.60M 163.92M 164.66M 164.68M 164.71M 164.17M
Normalized Net Operating Profit after Tax (NOPAT)
302 887 895 709 399 384 243 118 136 130
Normalized NOPAT Margin
5.28% 13.06% 13.70% 14.95% 11.16% 11.42% 7.18% 3.23% 4.00% 3.84%
Pre Tax Income Margin
4.33% 10.61% 13.68% 17.32% 9.90% 11.31% 3.48% 1.75% 3.61% 2.91%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
1.93 3.76 8.08 14.14 5.82 5.19 2.08 1.72 1.55 1.24
NOPAT to Interest Expense
2.13 3.36 6.85 11.40 5.04 4.42 2.08 3.96 1.44 1.17
EBIT Less CapEx to Interest Expense
0.62 1.62 4.96 9.72 1.97 1.23 -0.85 -1.36 -1.03 -0.94
NOPAT Less CapEx to Interest Expense
0.82 1.22 3.73 6.99 1.18 0.46 -0.85 0.87 -1.15 -1.01
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
3.77% 1.38% 0.61% 0.92% 2.08% 2.04% 9.68% 17.05% 1.45% 3.97%
Augmented Payout Ratio
15.76% 9.39% 17.41% 26.43% 20.41% 8.04% 9.68% 17.05% 6.11% 10.90%

Quarterly Metrics And Ratios for Darling Ingredients

This table displays calculated financial ratios and metrics derived from Darling Ingredients' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/29/2025 12/28/2024 9/28/2024 6/29/2024 3/30/2024 12/30/2023 9/30/2023 7/1/2023 4/1/2023 12/31/2022 10/1/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-2.80% -12.17% -12.51% -17.20% -20.71% -8.71% -7.00% 6.51% 31.09% 34.96% 47.36%
EBITDA Growth
-43.40% -13.65% -38.61% -43.76% -28.51% -17.11% -16.79% 32.54% 23.50% 24.92% 31.02%
EBIT Growth
-79.21% -19.32% -64.34% -59.27% -45.30% -33.89% -31.53% 32.99% 15.56% 16.95% 29.53%
NOPAT Growth
-84.81% 10.76% 244.81% -52.18% -41.57% -27.12% -10.63% 35.92% 9.34% 18.20% 42.00%
Net Income Growth
-129.19% 18.93% -85.08% -68.12% -57.03% -45.20% -33.40% 24.59% -0.46% 1.04% 29.75%
EPS Growth
-132.00% 18.87% -85.71% -68.39% -56.14% -44.21% -34.19% 26.02% 0.00% 0.00% 32.95%
Operating Cash Flow Growth
-5.66% -28.84% -0.77% -32.57% 40.06% 23.77% -0.29% 4.04% 23.81% -30.54% 80.00%
Free Cash Flow Firm Growth
714.92% 156.70% 165.21% 124.33% 101.84% 16.25% -5.28% -103.72% -1,980.46% -562.42% -807.24%
Invested Capital Growth
-5.99% -9.10% -3.05% -4.24% 1.22% 28.98% 31.58% 45.11% 84.49% 54.08% 44.25%
Revenue Q/Q Growth
-2.62% -0.30% -2.30% 2.46% -12.01% -0.68% -7.53% -1.87% 1.31% 1.17% 5.90%
EBITDA Q/Q Growth
-40.10% 36.99% -30.86% -0.22% -8.62% -2.61% -36.66% 26.84% 5.96% -2.25% 0.89%
EBIT Q/Q Growth
-76.68% 101.30% -56.38% 1.57% -9.53% -11.03% -50.18% 36.42% 9.34% -7.86% -3.24%
NOPAT Q/Q Growth
-87.76% -76.76% 375.09% 12.38% -10.74% -27.65% -34.11% 37.32% 11.33% -11.28% 0.21%
Net Income Q/Q Growth
-122.95% 442.91% -76.51% -0.27% -6.50% -31.87% -49.81% 34.42% 19.23% -17.20% -6.12%
EPS Q/Q Growth
-125.40% 472.73% -77.55% -2.00% -5.66% -31.17% -50.32% 35.96% 20.00% -18.80% -4.88%
Operating Cash Flow Q/Q Growth
61.25% -43.75% 87.33% -44.48% 21.63% -21.55% 27.30% 15.31% 7.49% -36.81% 32.83%
Free Cash Flow Firm Q/Q Growth
-46.31% -13.81% 109.42% 740.92% 103.74% 0.87% 21.87% 36.27% -69.67% -24.61% -51.19%
Invested Capital Q/Q Growth
1.55% -4.15% 0.09% -3.51% -1.80% 2.23% -1.14% 1.99% 25.13% 4.29% 9.04%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
22.55% 23.54% 22.05% 22.46% 21.38% 27.04% 23.78% 22.64% 23.68% 21.99% 21.54%
EBITDA Margin
11.27% 18.33% 13.34% 18.85% 19.36% 18.64% 19.01% 27.76% 21.47% 20.53% 21.25%
Operating Margin
2.06% 8.64% 4.23% 10.20% 9.66% 9.84% 10.98% 20.29% 14.28% 14.10% 15.35%
EBIT Margin
2.20% 9.19% 4.55% 10.19% 10.28% 10.00% 11.17% 20.72% 14.91% 13.81% 15.17%
Profit (Net Income) Margin
-1.72% 7.32% 1.34% 5.59% 5.74% 5.41% 7.88% 14.52% 10.60% 9.01% 11.00%
Tax Burden Percent
95.38% 132.66% 1,162.71% 99.06% 95.43% 92.33% 113.63% 86.24% 87.56% 80.74% 84.52%
Interest Burden Percent
-82.21% 60.06% 2.54% 55.37% 58.53% 58.53% 62.12% 81.24% 81.21% 80.77% 85.85%
Effective Tax Rate
0.00% -32.66% -1,062.71% 0.94% 4.57% 7.67% -13.63% 13.76% 12.44% 19.26% 15.48%
Return on Invested Capital (ROIC)
1.27% 10.17% 44.74% 9.47% 8.99% 10.30% 14.92% 21.94% 17.25% 17.25% 18.58%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.14% 7.02% 9.77% 6.23% 6.72% 6.79% 10.62% 18.72% 14.49% 11.15% 14.12%
Return on Net Nonoperating Assets (RNNOA)
-0.45% 2.84% 4.18% 2.82% 3.33% 2.67% 4.53% 7.59% 4.70% 2.12% 3.15%
Return on Equity (ROE)
0.83% 13.02% 48.91% 12.28% 12.31% 12.98% 19.45% 29.54% 21.95% 19.36% 21.73%
Cash Return on Invested Capital (CROIC)
13.54% 17.93% 11.03% 13.95% 10.63% -10.75% -11.32% -19.77% -41.98% -22.61% -16.72%
Operating Return on Assets (OROA)
1.19% 4.97% 2.52% 5.77% 6.05% 6.70% 7.90% 15.41% 11.87% 11.77% 12.50%
Return on Assets (ROA)
-0.93% 3.96% 0.74% 3.17% 3.38% 3.62% 5.58% 10.80% 8.44% 7.67% 9.07%
Return on Common Equity (ROCE)
0.81% 12.77% 48.00% 12.06% 12.06% 12.71% 19.03% 28.96% 21.49% 18.95% 21.25%
Return on Equity Simple (ROE_SIMPLE)
4.06% 0.00% 5.92% 8.48% 12.02% 0.00% 16.72% 18.24% 18.50% 0.00% 20.82%
Net Operating Profit after Tax (NOPAT)
20 162 699 147 131 147 203 308 224 201 227
NOPAT Margin
1.44% 11.46% 49.15% 10.11% 9.22% 9.09% 12.47% 17.50% 12.51% 11.38% 12.98%
Net Nonoperating Expense Percent (NNEP)
2.41% 3.16% 34.96% 3.23% 2.26% 3.51% 4.30% 3.22% 2.77% 6.10% 4.45%
Return On Investment Capital (ROIC_SIMPLE)
0.24% 1.91% - - - 1.61% - - - 2.76% -
Cost of Revenue to Revenue
77.45% 76.46% 77.95% 77.54% 78.62% 72.96% 76.22% 77.36% 76.32% 78.01% 78.46%
SG&A Expenses to Revenue
8.80% 7.58% 8.14% 8.91% 9.80% 8.22% 8.47% 7.78% 7.56% 6.88% 6.01%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
20.49% 14.91% 17.83% 12.26% 11.72% 17.20% 12.80% 2.35% 9.40% 7.89% 6.18%
Earnings before Interest and Taxes (EBIT)
30 130 65 148 146 161 181 364 267 244 265
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
156 260 190 274 275 301 309 488 385 363 371
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.13 1.22 1.32 1.32 1.62 1.73 1.90 2.33 2.32 2.63 2.96
Price to Tangible Book Value (P/TBV)
4.32 4.60 5.37 5.59 7.15 7.61 9.89 13.99 26.40 10.30 13.16
Price to Revenue (P/Rev)
0.88 0.93 1.02 0.96 1.16 1.17 1.20 1.44 1.34 1.54 1.75
Price to Earnings (P/E)
29.22 19.08 22.96 15.89 13.66 12.28 11.57 12.95 12.70 13.60 14.40
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
3.42% 5.24% 4.35% 6.29% 7.32% 8.15% 8.65% 7.72% 7.87% 7.35% 6.95%
Enterprise Value to Invested Capital (EV/IC)
1.09 1.15 1.23 1.22 1.43 1.50 1.60 1.87 1.81 2.19 2.40
Enterprise Value to Revenue (EV/Rev)
1.20 1.24 1.33 1.28 1.47 1.49 1.52 1.77 1.70 1.75 1.98
Enterprise Value to EBITDA (EV/EBITDA)
7.72 7.08 7.55 6.73 6.88 6.81 6.82 7.77 7.97 8.10 8.98
Enterprise Value to EBIT (EV/EBIT)
18.17 14.45 15.08 12.24 11.07 10.36 9.97 10.94 11.28 11.29 12.30
Enterprise Value to NOPAT (EV/NOPAT)
14.34 13.08 15.23 12.41 12.12 11.58 11.38 13.00 13.49 13.31 14.54
Enterprise Value to Operating Cash Flow (EV/OCF)
8.23 8.43 8.70 8.63 9.69 11.22 12.29 14.54 13.94 14.07 13.52
Enterprise Value to Free Cash Flow (EV/FCFF)
7.80 6.13 10.95 8.56 13.50 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.86 0.91 0.92 0.97 0.95 0.94 0.99 1.02 1.13 0.87 0.90
Long-Term Debt to Equity
0.84 0.88 0.89 0.95 0.93 0.93 0.97 1.00 1.11 0.85 0.88
Financial Leverage
0.39 0.41 0.43 0.45 0.49 0.39 0.43 0.41 0.32 0.19 0.22
Leverage Ratio
2.28 2.31 2.35 2.40 2.48 2.36 2.41 2.37 2.29 2.12 2.12
Compound Leverage Factor
-1.87 1.39 0.06 1.33 1.45 1.38 1.50 1.93 1.86 1.71 1.82
Debt to Total Capital
46.37% 47.52% 47.82% 49.26% 48.81% 48.54% 49.69% 50.54% 53.16% 46.49% 47.24%
Short-Term Debt to Total Capital
1.38% 1.56% 1.29% 1.03% 1.13% 0.67% 0.83% 0.98% 1.35% 0.96% 0.92%
Long-Term Debt to Total Capital
44.99% 45.95% 46.53% 48.23% 47.69% 47.87% 48.86% 49.56% 51.81% 45.53% 46.32%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.03% 1.02% 0.93% 0.91% 0.98% 0.97% 0.97% 0.92% 1.01% 1.20% 1.28%
Common Equity to Total Capital
52.60% 51.47% 51.25% 49.83% 50.20% 50.49% 49.34% 48.55% 45.83% 52.31% 51.49%
Debt to EBITDA
4.46 4.05 4.08 3.80 3.25 2.99 2.86 2.83 3.15 2.39 2.45
Net Debt to EBITDA
1.92 1.67 1.69 1.59 1.41 1.38 1.38 1.38 1.63 0.94 1.00
Long-Term Debt to EBITDA
4.33 3.91 3.97 3.72 3.18 2.95 2.81 2.77 3.07 2.34 2.40
Debt to NOPAT
8.29 7.47 8.24 7.01 5.73 5.08 4.76 4.74 5.33 3.93 3.97
Net Debt to NOPAT
3.57 3.08 3.42 2.94 2.49 2.35 2.30 2.31 2.75 1.55 1.62
Long-Term Debt to NOPAT
8.04 7.23 8.02 6.87 5.60 5.01 4.69 4.64 5.19 3.85 3.89
Altman Z-Score
1.73 1.78 1.75 1.78 1.90 1.98 2.05 2.23 2.06 2.48 2.57
Noncontrolling Interest Sharing Ratio
1.92% 1.91% 1.86% 1.82% 2.03% 2.05% 2.15% 1.94% 2.09% 2.13% 2.20%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.40 1.38 1.41 1.57 1.67 1.86 1.78 1.85 1.73 1.53 1.52
Quick Ratio
0.66 0.64 0.65 0.73 0.80 0.93 0.83 0.85 0.80 0.75 0.77
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
416 776 900 430 51 -1,368 -1,380 -1,766 -2,772 -1,634 -1,311
Operating Cash Flow to CapEx
395.31% 210.55% 407.19% 149.58% 281.43% 124.04% 189.12% 176.67% 169.25% 130.64% 262.59%
Free Cash Flow to Firm to Interest Expense
7.18 14.13 13.46 6.21 0.81 -19.99 -19.64 -25.17 -55.10 -35.40 -32.93
Operating Cash Flow to Interest Expense
4.29 2.81 4.11 2.12 4.20 3.17 3.94 3.10 3.75 3.80 6.97
Operating Cash Flow Less CapEx to Interest Expense
3.21 1.48 3.10 0.70 2.71 0.61 1.85 1.34 1.53 0.89 4.31
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.54 0.54 0.55 0.57 0.59 0.67 0.71 0.74 0.80 0.85 0.82
Accounts Receivable Turnover
9.30 8.23 9.01 9.24 9.33 9.21 9.88 10.69 10.97 11.40 10.57
Inventory Turnover
6.84 6.64 6.29 6.42 6.45 7.18 7.30 7.80 8.10 8.85 8.25
Fixed Asset Turnover
2.01 2.02 2.09 2.18 2.28 2.52 2.70 2.82 3.04 3.04 2.91
Accounts Payable Turnover
12.69 11.46 12.47 12.01 12.59 11.45 13.48 13.02 13.63 12.83 13.75
Days Sales Outstanding (DSO)
39.26 44.35 40.51 39.51 39.10 39.65 36.95 34.14 33.28 32.01 34.53
Days Inventory Outstanding (DIO)
53.33 54.93 58.02 56.88 56.56 50.83 50.02 46.77 45.05 41.26 44.25
Days Payable Outstanding (DPO)
28.76 31.85 29.26 30.40 28.99 31.87 27.08 28.04 26.79 28.44 26.55
Cash Conversion Cycle (CCC)
63.83 67.43 69.27 65.98 66.67 58.61 59.89 52.86 51.55 44.83 52.23
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,224 6,129 6,394 6,389 6,621 6,742 6,596 6,671 6,541 5,228 5,013
Invested Capital Turnover
0.88 0.89 0.91 0.94 0.98 1.13 1.20 1.25 1.38 1.52 1.43
Increase / (Decrease) in Invested Capital
-397 -613 -201 -283 80 1,515 1,583 2,074 2,996 1,835 1,538
Enterprise Value (EV)
6,788 7,073 7,848 7,800 9,448 10,088 10,540 12,482 11,849 11,450 12,041
Market Capitalization
5,012 5,322 6,005 5,872 7,420 7,951 8,325 10,179 9,341 10,031 10,609
Book Value per Share
$28.00 $27.53 $28.62 $27.92 $28.75 $28.87 $27.47 $27.38 $25.21 $23.77 $22.32
Tangible Book Value per Share
$7.31 $7.27 $7.03 $6.57 $6.49 $6.55 $5.28 $4.56 $2.21 $6.07 $5.03
Total Capital
8,457 8,506 8,881 8,952 9,149 9,121 8,879 8,997 8,799 7,281 6,953
Total Debt
3,922 4,042 4,246 4,409 4,466 4,427 4,412 4,547 4,677 3,385 3,285
Total Long-Term Debt
3,805 3,909 4,132 4,317 4,363 4,366 4,338 4,459 4,559 3,315 3,221
Net Debt
1,688 1,665 1,760 1,846 1,938 2,049 2,129 2,221 2,419 1,331 1,344
Capital Expenditures (CapEx)
63 73 67 98 94 175 146 123 111 134 106
Debt-free, Cash-free Net Working Capital (DFCFNWC)
414 415 395 489 606 791 764 839 789 512 472
Debt-free Net Working Capital (DFNWC)
536 529 549 637 755 918 883 950 922 640 598
Net Working Capital (NWC)
419 396 434 544 652 858 809 862 803 570 534
Net Nonoperating Expense (NNE)
44 59 680 66 49 59 75 52 34 42 34
Net Nonoperating Obligations (NNO)
1,688 1,665 1,760 1,846 1,938 2,049 2,129 2,221 2,419 1,331 1,344
Total Depreciation and Amortization (D&A)
125 130 125 126 129 139 128 124 118 119 106
Debt-free, Cash-free Net Working Capital to Revenue
7.30% 7.27% 6.67% 7.99% 9.44% 11.66% 11.00% 11.87% 11.35% 7.84% 7.76%
Debt-free Net Working Capital to Revenue
9.44% 9.26% 9.28% 10.41% 11.77% 13.53% 12.72% 13.45% 13.26% 9.79% 9.84%
Net Working Capital to Revenue
7.38% 6.93% 7.35% 8.90% 10.16% 12.63% 11.66% 12.21% 11.55% 8.72% 8.79%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.16) $0.64 $0.11 $0.49 $0.51 $0.53 $0.78 $1.58 $1.16 $0.97 $1.19
Adjusted Weighted Average Basic Shares Outstanding
158.16M 158.87M 159.05M 159.02M 159.78M 159.61M 159.53M 159.49M 159.56M 159.95M 160.27M
Adjusted Diluted Earnings per Share
($0.16) $0.63 $0.11 $0.49 $0.50 $0.53 $0.77 $1.55 $1.14 $0.95 $1.17
Adjusted Weighted Average Diluted Shares Outstanding
158.16M 158.87M 159.05M 159.02M 159.78M 159.61M 159.53M 159.49M 159.56M 159.95M 160.27M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
158.16M 158.87M 159.05M 159.02M 159.78M 159.61M 159.53M 159.49M 159.56M 159.95M 160.27M
Normalized Net Operating Profit after Tax (NOPAT)
25 85 54 116 110 157 124 304 234 221 228
Normalized NOPAT Margin
1.80% 6.03% 3.78% 7.95% 7.75% 9.76% 7.63% 17.27% 13.06% 12.47% 13.04%
Pre Tax Income Margin
-1.81% 5.52% 0.12% 5.64% 6.02% 5.85% 6.94% 16.84% 12.11% 11.15% 13.02%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.52 2.37 0.97 2.14 2.32 2.36 2.58 5.19 5.31 5.29 6.66
NOPAT to Interest Expense
0.34 2.96 10.46 2.13 2.08 2.14 2.88 4.38 4.45 4.36 5.70
EBIT Less CapEx to Interest Expense
-0.56 1.04 -0.04 0.73 0.83 -0.20 0.50 3.44 3.10 2.38 4.00
NOPAT Less CapEx to Interest Expense
-0.74 1.62 9.45 0.71 0.59 -0.41 0.80 2.63 2.24 1.45 3.04
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 3.77% 3.40% 1.67% 0.00% 1.38% 1.30% 1.17% 0.00% 0.61% 0.78%
Augmented Payout Ratio
38.21% 15.76% 14.24% 9.38% 1.66% 9.39% 11.60% 15.31% 20.39% 17.41% 23.97%

Frequently Asked Questions About Darling Ingredients' Financials

When does Darling Ingredients's fiscal year end?

According to the most recent income statement we have on file, Darling Ingredients' financial year ends in December. Their financial year 2024 ended on December 28, 2024.

How has Darling Ingredients' net income changed over the last 9 years?

Darling Ingredients' net income appears to be on an upward trend, with a most recent value of $285.85 million in 2024, rising from $85.28 million in 2015. The previous period was $660.39 million in 2023. See Darling Ingredients' forecast for analyst expectations on what’s next for the company.

What is Darling Ingredients's operating income?
Darling Ingredients's total operating income in 2024 was $468.22 million, based on the following breakdown:
  • Total Gross Profit: $1.28 billion
  • Total Operating Expenses: $809.62 million
How has Darling Ingredients revenue changed over the last 9 years?

Over the last 9 years, Darling Ingredients' total revenue changed from $3.39 billion in 2015 to $5.72 billion in 2024, a change of 68.5%.

How much debt does Darling Ingredients have?

Darling Ingredients' total liabilities were at $5.61 billion at the end of 2024, a 12.0% decrease from 2023, and a 101.2% increase since 2015.

How much cash does Darling Ingredients have?

In the past 9 years, Darling Ingredients' cash and equivalents has ranged from $68.91 million in 2021 to $156.88 million in 2015, and is currently $75.97 million as of their latest financial filing in 2024.

How has Darling Ingredients' book value per share changed over the last 9 years?

Over the last 9 years, Darling Ingredients' book value per share changed from 11.36 in 2015 to 27.53 in 2024, a change of 142.4%.



This page (NYSE:DAR) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners